PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-human CD57, 25 tests
PE/Dazzle™ 594 anti-human CD62L, 100 tests
PE/Dazzle™ 594 anti-human CD62L, 25 tests
PE/Dazzle™ 594 anti-human CD63, 100 tests
PE/Dazzle™ 594 anti-human CD63, 25 tests
PE/Dazzle™ 594 anti-human CD64, 100 tests
PE/Dazzle™ 594 anti-human CD64, 25 tests
PE/Dazzle™ 594 anti-human CD66b, 100 tests
PE/Dazzle™ 594 anti-human CD66b, 25 tests
PE/Dazzle™ 594 anti-human CD69, 100 tests
PE/Dazzle™ 594 anti-human CD69, 25 tests
PE/Dazzle™ 594 anti-human CD73 (Ecto-5'-nucleotidase), 100 tests
PE/Dazzle™ 594 anti-human CD73 (Ecto-5'-nucleotidase), 25 tests
PE/Dazzle™ 594 anti-human CD8, 100 tests
PE/Dazzle™ 594 anti-human CD8, 25 tests
PE/Dazzle™ 594 anti-human CD80, 100 tests